Inventiva says last patient visit in lanifibranor Nativ3 Phase 3
Inventiva SA said the last patient visit has been completed in its Nativ3 Phase 3 clinical trial of lanifibranor in MASH.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.